Rivaroxaban Induced Thrombocytosis: A Perplexing Clinical Challenge
- 94 Downloads
The authors haven’t received any external funding.
Compliance with Ethical Standards
Conflict of interest
The authors both declare that they have no conflict of interest.
Informed consent was obtained from the patient.
- 1.CHMP Annex I Summary of Product Characteristics: Rivaroxaban. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000944/WC500057108.pdf. Accessed 24 Nov 2017
© Indian Society of Hematology and Blood Transfusion 2018